Effect of Mavacamten on reducing sudden cardiac death risk in patients with Obstructive Hypertrophic Cardiomyopathy: an evaluation using the HCM-SCD Risk Score

30 March 2025 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias Diagnostic Methods EHRA Premium Access EHRA 2025 European Heart Rhythm Association (EHRA)

ESC 365 is supported by

ESC 365 is supported by